Skip to main content

Table 1 Patient characteristics. Patient characteristics and clinical data presented as mean (2 ± SD) or absolute number as appropriate

From: Supraclavicular block with Mepivacaine vs Ropivacaine, their impact on postoperative pain: a prospective randomised study

 

SCB-mepivacaine (n = 27)

SCB-ropivacaine (n = 28)

GA

(n = 29)

p-value

Gender (male/female)

3/24

3/25

4/25

0.93

Age (yr)

60.3

(±10.4)

62.3

(±13.1)

57.4

(±15.3)

0.51

Height (cm)

168.6

(±6.1)

168.2

(±6.9)

169.2

(±8.9)

 

Weight (kg)

65.3

(±7.9)

70.8

(12.2)

72.6

(±13.1)

 

BMI (kg m− 2)

22.9

(±2.3)

25.0

(±3.7)

25.3

(±3.9)

0.03

Tobacco user:

    

Smoking (yes/no)

3/24

3/25

2/27

0.84

Snuffing (yes/no)

2/25

0/28

0/29

0.10

ASA (1/2/3)

13/13/1

9/19/0

9/20/0

0.32

Days from injury to operation

8.4

(±3.1)

10.0

(±4.2)

9.4

(±3.4)

0.27

Injury to dominant hand (yes/no)

8/19

11/17

11/18

0.72

Apfel score before surgery and pain medication (1–4)

3.07

(±0.62)

3.07

(±0.77)

3.31

(±0.85)

0.22

Previous PONV/ history of motion sickness (yes/no)

9/18

10/18

15/14

0.31

  1. Classification of patients´ health and comorbidity level by the American Society of Anesthesiologists (ASA) system. Postoperative nausea and vomiting (PONV), Body mass index (BMI). Supraclavicular block (SCB), General anaesthesia (GA). Apfel score; riskfactors 1–4 for PONV